Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.27) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.02, RTT News reports. The company had revenue of $58.36 million for the quarter, compared to analyst estimates of $57.96 million. Pacific Biosciences […]
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) announced its quarterly earnings results on Thursday. The biotechnology company reported ($0.27) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.02, RTT News reports. Pacific Biosciences of California had a negative return on equity of 40.26% and a negative net margin […]
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) announced its earnings results on Thursday. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.02, RTT News reports. The business had revenue of $58.36 million for the quarter, compared to analysts’ expectations of $57.96 million. […]
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) posted its quarterly earnings data on Thursday. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.02, RTT News reports. The company had revenue of $58.36 million during the quarter, compared to the consensus estimate of […]
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.27) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.02, RTT News reports. The company had revenue of $58.36 million for the quarter, compared to analyst estimates of $57.96 million. Pacific Biosciences […]